Dystrophin and mutations: one gene, several proteins, multiple phenotypes

被引:761
作者
Muntoni, F
Torelli, S
Ferlini, A
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dubowitz Neuromuscular Unit, Dept Paediat, London W12 0NN, England
[2] Univ Ferrara, Dipartimento Med Sperimentale & Diagnost, Sez Genet Med, I-44100 Ferrara, Italy
关键词
D O I
10.1016/S1474-4422(03)00585-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A large and complex gene on the X chromosome encodes dystrophin. Many mutations have been described in this gene, most of which affect the expression of the muscle isoform, the best-known protein product of this locus. These mutations result in the Duchenne and Becker muscular dystrophies (DMD and BMD). However, there are several other tissue specific isoforms of dystrophin, some exclusively or predominantly expressed in the brain or the retina. Mutations affecting the correct expression of these tissue-specific isoforms have been associated with the CNS involvement common in DMD. Rare mutations also account for the allelic disorder X-linked dilated cardiomyopathy, in which dystrophin expression or function is affected mostly or exclusively in the heart. Genotype definition of the dystrophin gene in patients with dystrophinopathies has taught us much about functionally important domains of the protein itself and has provided insights into several regulatory mechanisms governing the gene expression profile. Here, we focus on current understanding of the genotype-phenotype relation for mutations in the dystrophin gene and their implications for gene functions.
引用
收藏
页码:731 / 740
页数:10
相关论文
共 151 条
  • [1] Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy
    Aartsma-Rus, A
    Bremmer-Bout, M
    Janson, AAM
    den Dunnen, JT
    van Ommen, GJB
    van Deutekom, JCT
    [J]. NEUROMUSCULAR DISORDERS, 2002, 12 : S71 - S77
  • [2] Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients
    Aartsma-Rus, A
    Janson, AAM
    Kaman, WE
    Bremmer-Bout, M
    den Dunnen, JT
    Baas, F
    van Ommen, GJB
    van Deutekom, JCT
    [J]. HUMAN MOLECULAR GENETICS, 2003, 12 (08) : 907 - 914
  • [3] ANALYSIS OF QUANTITATIVE PCR FOR THE DIAGNOSIS OF DELETION AND DUPLICATION CARRIERS IN THE DYSTROPHIN GENE
    ABBS, S
    BOBROW, M
    [J]. JOURNAL OF MEDICAL GENETICS, 1992, 29 (03) : 191 - 196
  • [4] Brain function in Duchenne muscular dystrophy
    Anderson, JL
    Head, SI
    Rae, C
    Morley, JW
    [J]. BRAIN, 2002, 125 : 4 - 13
  • [5] Prognostic factors in mild dystrophinopathies
    Angelini, C
    Fanin, M
    Freda, MP
    Martinello, F
    Miorin, M
    Melacini, P
    Siciliano, G
    Pegoraro, E
    Rosa, M
    Danieli, GA
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 142 (1-2) : 70 - 78
  • [6] PRESERVATION OF THE C-TERMINUS OF DYSTROPHIN MOLECULE IN THE SKELETAL-MUSCLE FROM BECKER MUSCULAR-DYSTROPHY
    ARAHATA, K
    BEGGS, AH
    HONDA, H
    ITO, S
    ISHIURA, S
    TSUKAHARA, T
    ISHIGURO, T
    EGUCHI, C
    ORIMO, S
    ARIKAWA, E
    KAIDO, M
    NONAKA, I
    SUGITA, H
    KUNKEL, LM
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1991, 101 (02) : 148 - 156
  • [7] AUSTIN RC, 1995, HUM MOL GENET, V4, P1475
  • [8] A NOVEL PRODUCT OF THE DUCHENNE MUSCULAR-DYSTROPHY GENE WHICH GREATLY DIFFERS FROM THE KNOWN ISOFORMS IN ITS STRUCTURE AND TISSUE DISTRIBUTION
    BAR, S
    BARNEA, E
    LEVY, Z
    NEUMAN, S
    YAFFE, D
    NUDEL, U
    [J]. BIOCHEMICAL JOURNAL, 1990, 272 (02) : 557 - 560
  • [9] A novel muscle-specific enhancer identified within the deletion overlap region of two XLDC patients lacking muscle exon 1 of the human dystrophin gene
    Bastianutto, C
    De Visser, M
    Muntoni, F
    Klamut, HJ
    Patarnello, T
    [J]. GENOMICS, 2002, 80 (06) : 614 - 620
  • [10] MOLECULAR AND CLINICAL CORRELATIONS OF DELETIONS LEADING TO DUCHENNE AND BECKER MUSCULAR-DYSTROPHIES
    BAUMBACH, LL
    CHAMBERLAIN, JS
    WARD, PA
    FARWELL, NJ
    CASKEY, CT
    [J]. NEUROLOGY, 1989, 39 (04) : 465 - 474